| 000 | 01882 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514191718.0 | ||
| 264 | 0 | _c20040625 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0885-0666 | ||
| 024 | 7 |
_a10.1177/0885066602239122 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartin, Eike | |
| 245 | 0 | 0 |
_aThe role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. _h[electronic resource] |
| 260 |
_bJournal of intensive care medicine _c |
||
| 300 |
_a29-41 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdrenergic alpha-2 Receptor Agonists |
| 650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBradycardia _xchemically induced |
| 650 | 0 | 4 |
_aConscious Sedation _xmethods |
| 650 | 0 | 4 |
_aCritical Care _xmethods |
| 650 | 0 | 4 |
_aDexmedetomidine _xpharmacology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xpharmacology |
| 650 | 0 | 4 |
_aHypotension _xchemically induced |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostoperative Care _xmethods |
| 650 | 0 | 4 |
_aPropofol _xpharmacology |
| 650 | 0 | 4 |
_aRespiration _xdrug effects |
| 650 | 0 | 4 | _aVentilator Weaning |
| 700 | 1 | _aRamsay, Graham | |
| 700 | 1 | _aMantz, Jean | |
| 700 | 1 | _aSum-Ping, S T John | |
| 773 | 0 |
_tJournal of intensive care medicine _gvol. 18 _gno. 1 _gp. 29-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0885066602239122 _zAvailable from publisher's website |
| 999 |
_c14896489 _d14896489 |
||